| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Bodenstedt Matthias is a Chief Financial Officer at MLTX. Recent filings cover 1 purchase and 4 sales. Those positions are worth an estimated $19.0M at current prices.
Our model assigns Bodenstedt Matthias a middling insider score of 66/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +11.2%.
Bodenstedt Matthias's largest disclosed position is in MLTX as Chief Financial Officer, worth about $19.0M. The recent filings there lean toward selling, a net 107,006 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | MLTX Moonlake Immunotherapeutics | Chief Financial Officer | Sell | 17,876 | $19.67 | $351,576.16 | -0.8% | - | - | |
| Oct 8, 2025 | MLTX Moonlake Immunotherapeutics | Chief Financial Officer | Buy | 10,870 | $9.09 | $98,808.30 | +1.8% | +22.7% | - | |
| Dec 20, 2023 | MLTX Moonlake Immunotherapeutics | Chief Financial Officer | Sell | 100,000 | $59.17 | $5,917,367.68 | -8.7% | -12.1% | -9.8% |